Abstract
Acute viral respiratory infections add to the progression risk of the already existing pathologies, including those of cardiovascular origin. Life-threatening complications emerging against SARS-CoV-2 (severe acute respiratory syndrome), which causes COVID-19 (Coronavirus disease 2019), explain the need to study the cardiovascular effects of COVID-19 in order to offer rational medical care to patients belonging to various age categories. This article presents a comprehensive assessment of changes affecting the main hemostasis parameters in patients with acute cerebral circulatory disorders against the SARS-CoV-2 virus infection. There is special attention paid to the pathophysiological features occurring against the infectious process involving the hemostasis system. Our data shows that the differences in the main hemostatic parameters in patients with acute cerebral circulatory disorders occurring against the SARS-CoV-2 virus infection are due to the degree of the body responsiveness and the severity of the comorbid pathology. Reducing the risk of adverse conditions developing in this category of patients is possible in case of responsible monitoring focusing on the main indicators of the cardiovascular system status, as well as provided there are advanced approaches introduced in order to prevent and treat thrombotic/thromboembolic complications.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
